Document is current

Any future updates will be listed below

Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study

Crossref DOI link: https://doi.org/10.1007/s13300-020-00778-1

Published Online: 2020-02-17

Published Print: 2020-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark